RxDoctor Payments Data

Feryal Golzary Pour

Acute Care · San Gabriel, CANPI 1316564057

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations.

$1,655in general payments, 2019–2025

Across 73 payments — averaging $22.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$217
  • GSK$206
  • AstraZeneca$148
  • AbbVie$139
  • Kowa Pharmaceuticals America, Inc.$90
  • Otsuka America Pharmaceutical, Inc.$89
  • plus $766 from 17 others

What the payments were for

  • Speaking & faculty fees$211%
  • Food & beverage$1,63499%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,655 in reported general payments places this provider in the 80th percentile of 1,153 acute care providers in California.

See all acute care providers in California →

Other acute care in San Gabriel

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →